Volume 10, Issue 2 (Vol.10 No.2 Jul 2021)                   rbmb.net 2021, 10(2): 243-256 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Noohi M, Hakemi-vala M, Nowroozi J, Fatemi S, Dezfulian M. Prediction of Blood miRNA-mRNA Regulatory Network in Gastric Cancer. rbmb.net 2021; 10 (2) :243-256
URL: http://rbmb.net/article-1-598-en.html
Department of Microbiology, Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:   (2866 Views)
Background: The aim of the study was to suggest a high specific and sensitive blood biomarker for early GC diagnosis.
Methods: the expression data of miRNAs and mRNAs were collected from the blood samples of the GC patients based on literature mining. Bioinformatics tools and databases (PANTHER, TargetScan, miRTarBase, miRDB, STRING, and Cytoscape) were used to predict the regulatory relationship. Subsequently, expression level of the selected miRNA was evaluated in the blood samples of gastritis patients to recognize the common miRNA between the GC and gastritis patients.

Results: Analysis of 40 target genes by MCODE (installed in Cytoscape software) indicated 4 hub genes (WWP1, SKP2, KLHL42, and FBXO11) as a significant cluster in the PPI network related to miR-21, with Node Score Cutoff: 0.2, Degree Cutoff: 2 and K-Core: 2. In addition, the miRNA RT-qPCR results showed that, the expression level of miR-21 was significantly higher in gastritis group compared to the healthy group (p< 0.05).

Conclusions: the present study clearly demonstrated the increasing level of blood miR-21 among the gastritis patients infected by H. pylori. Therefore, the altered miRNAs, especially overexpression of onco-miRs, may identify a potential link between miRNAs and pathogenesis of the H. pylori–related complications.
Full-Text [PDF 744 kb]   (1284 Downloads)    
Type of Article: Original Article | Subject: Molecular Biology
Received: 2020/11/4 | Accepted: 2020/11/15 | Published: 2021/08/26

References
1. Leal M, AssumpÇÃo P, Smith M, Burbano R. Searching for Gastric Cancer Biomarkers Through Proteomic Approaches. Journal of Gastroenterology and Hepatology Research. 2014; 3:989-995.
2. Liu B, R Yuan, Z Lianga, T Zhanga, M Zhua, X Zhanga, et al. Comprehensive analysis of circRNA expression pattern and circRNA-mRNA-miRNA network in Ctenopharyngodon idellus kidney (CIK) cells after grass carp reovirus (GCRV) infection. Aquaculture. 2019;512:734349. [DOI:10.1016/j.aquaculture.2019.734349]
3. Shu L, Wang Z, Wang Q, Wang Y, Zhanget X, et al. Signature miRNAs in peripheral blood monocytes of patients with gastric or breast cancers. Royal Society Open Biology. 2018;8(10). [DOI:10.1098/rsob.180051] [PMID] [PMCID]
4. Miranda KC, Huynh T, Tay Y, Ang Y, Tam W, Thomson AM, et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006;126(6):1203-17. [DOI:10.1016/j.cell.2006.07.031] [PMID]
5. Xu P, M Guo, BA Hay. MicroRNAs and the regulation of cell death. Trends Genet. 2004;20(12):617-24. [DOI:10.1016/j.tig.2004.09.010] [PMID]
6. Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest. 2008;88(12):1358-66. [DOI:10.1038/labinvest.2008.94] [PMID]
7. Jiang F, Shen X. Current prevalence status of gastric cancer and recent studies on the roles of circular RNAs and methods used to investigate circular RNAs. Cell Mol Biol Lett. 2019;24:53. [DOI:10.1186/s11658-019-0178-5] [PMID] [PMCID]
8. Kusters JG, AH van Vliet, EJ Kuipers. Pathogenesis of Helicobacter pylori infection. Clinical microbiology reviews. 2006;19(3):449-490. [DOI:10.1128/CMR.00054-05] [PMID] [PMCID]
9. Li T, Shao Y, Fu L, Xie Y, Zhu L, Sun W. Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection. J Mol Med (Berl). 2018;96(1):85-96. [DOI:10.1007/s00109-017-1600-y] [PMID]
10. Zabaleta J, MicroRNA: a bridge from H. pylori infection to gastritis and gastric cancer development. Front Genet. 2012;3:294. [DOI:10.3389/fgene.2012.00294] [PMID] [PMCID]
11. Abramowicz A, Wojakowska A, Gdowicz-Klosok A, Polanska J, Rodziewicz P, Polanowski P, et al. Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study. J Transl Med. 2015;13:304. [DOI:10.1186/s12967-015-0668-9] [PMID] [PMCID]
12. Shen Q, Moghaddam M. A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer. EBioMedicine. 2019;44:322-333. [DOI:10.1016/j.ebiom.2019.05.044] [PMID] [PMCID]
13. Yoo, MW, et al. Discovery of gastric cancer specific biomarkers by the application of serum proteomics. Proteomics. 2017;17(6). [DOI:10.1002/pmic.201600332] [PMID]
14. Corder EH, GD Mellick. Parkinson's disease in relation to pesticide exposure and nuclear encoded mitochondrial complex I gene variants. J Biomed Biotechnol. 2006;2006:27601. [DOI:10.1155/JBB/2006/27601] [PMID] [PMCID]
15. Yang L, Wang J, Li J, H Zhang, Guo S, Yanet M, et al. Identification of serum biomarkers for gastric cancer diagnosis using a human proteome microarray. Mol Cell Proteomics. 2016;15(2):614-23. [DOI:10.1074/mcp.M115.051250] [PMID] [PMCID]
16. Shi J, Cheng Ch, Ma J, Liew Ch, Geng X, et al. Gene expression signature for detection of gastric cancer in peripheral blood. Oncol Lett. 2018;15(6):9802-9810. [DOI:10.3892/ol.2018.8577] [PMID] [PMCID]
17. Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M, H Takeshitaet, et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre-and post-operative plasma. B j cancer. 2012;106(4):740-747. [DOI:10.1038/bjc.2011.588] [PMID] [PMCID]
18. Cai H, Yuan Y, Hao Y, Guo T, Wei X, Zhang Y, et al. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol. 2013;30(1):452. [DOI:10.1007/s12032-012-0452-0] [PMID]
19. Gorur A, Balci Fidanci S, Dogruer Unal N, Ayaz L, Akbayir S, Yildirim H, Yaroglu Y, et al. Determination of plasma microRNA for early detection of gastric cancer. Mol Biol Rep. 2013;40(3):2091-6. [DOI:10.1007/s11033-012-2267-7] [PMID]
20. Li C, Fang Li J, Cai Q, Qiu Q, Yan M, B Ya Liu, et al. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer. Ann Surg Oncol. 2013;20 Suppl 3:S397-405. [DOI:10.1245/s10434-012-2600-3] [PMID]
21. Zhu C, Ren C, Han J, Ding Y, Du J, Dai N, et al. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br J Cancer. 2014;110(9):2291-2299. [DOI:10.1038/bjc.2014.119] [PMID] [PMCID]
22. Qiu X, Zhang J, Shi W, Liu S, Kang M, Chu H, et al. Circulating microRNA-26a in plasma and its potential diagnostic value in gastric cancer. PloS one. 2016;11(3):e0151345. [DOI:10.1371/journal.pone.0151345] [PMID] [PMCID]
23. Huang S, et al., Serum microRNA expression profile as a diagnostic panel for gastric cancer. Jpn J Clin Oncol. 2016;46(9):811-818. [DOI:10.1093/jjco/hyw085] [PMID]
24. Liu HN, Wu H, Tseng Y, Chen Y, Zhang D, Zhu L, et al. Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer. BMC cancer. 2018;18(1):415. [DOI:10.1186/s12885-018-4343-4] [PMID] [PMCID]
25. Liu R, Zhang C, Hu Z, Li G, Wang C, Yanget C, et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer. 2011;47(5):784-91. [DOI:10.1016/j.ejca.2010.10.025] [PMID]
26. Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer letters. 2012;316(2):196-203. https://doi.org/10.1016/j.canlet.2011.10.034 [DOI:10.1016/j.canlet.2012.09.013] [PMID]
27. Song My, Pan K, Su H, Zhang L, Ma J, Li Jy, et al. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PloS one. 2012;7(3):e33608. [DOI:10.1371/journal.pone.0033608] [PMID] [PMCID]
28. Sierzega M, Kaczor M, Kolodziejczyk P, Kulig J, Sanak M, Richteret P et al. Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331. Br J Cancer. 2017;117(2):266-273. [DOI:10.1038/bjc.2017.190] [PMID] [PMCID]
29. Matsushima, K, Isomoto H, Inoue N, Nakayama T, Hayashi T, Nakayama M, et al. MicroRNA signatures in Helicobacter pylori‐infected gastric mucosa. Int J Cancer. 2011;128(2):361-70. [DOI:10.1002/ijc.25348] [PMID]
30. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, et al. Differential expression of microRNA species in human gastric cancer versus non‐tumorous tissues. J Gastroenterol Hepatol. 2009;24(4):652-7. [DOI:10.1111/j.1440-1746.2008.05666.x] [PMID]
31. Kim, Y.-K., Yu J, Han TS, Park S, Namkoong B, Kimet DH, et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009;37(5):1672-81. [DOI:10.1093/nar/gkp002] [PMID] [PMCID]
32. Noto JM, RM, Peek Jr. The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis. Front Cell Infect Microbiol. 2012;1:21. [DOI:10.3389/fcimb.2011.00021] [PMID] [PMCID]
33. Volinia S, Calin GA, Liu C, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103(7):2257-61. [DOI:10.1073/pnas.0510565103] [PMID] [PMCID]
34. Libânio D, M Dinis-Ribeiro, P Pimentel-Nunes. Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions. World J Clin Oncol. 2015;6(5):111-32. [DOI:10.5306/wjco.v6.i5.111] [PMID] [PMCID]
35. Liu L, Chen Qi, Lai R, Wu X, Wu X, Liu F, et al. Elevated expression of mature miR-21 and miR-155 in cancerous gastric tissues from Chinese patients with gastric cancer. J Biomed Res. 2010;24(3):187-197. [DOI:10.1016/S1674-8301(10)60028-0]
36. Kim SS, Meitner P, Konkin T, Cho YS, MB Resnick, Moss SF, et al. Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis. Modern Pathology. 2006;19:49-58. [DOI:10.1038/modpathol.3800476] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2015 All Rights Reserved | Reports of Biochemistry and Molecular Biology

Designed & Developed by : Yektaweb